✦ LIBER ✦

W1198 Factors Associated With Indeterminable Results of Interferon Gamma Release Assay (IGRA) in Routine Screening for Latent Tuberculosis (LTB) in Patients With Inflammatory Bowel Diseases (IBD)

✍ Scribed by Papay, Pavol; Eser, Alexander; Primas, Christian; Frantal, Sophie; Vogelsang, Harald; Novacek, Gottfried; Reinisch, Walter

Book ID: 123346758
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 69 KB
Volume: 138
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(10)63092-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Factors impacting the results of interfe

Factors impacting the results of interferon-γ release assay and tuberculin skin test in routine screening for latent tuberculosis in patients with inflammatory bowel diseases

✍ Pavol Papay; Alexander Eser; Stefan Winkler; Sophie Frantal; Christian Primas; W 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 1 views

Diagnosis of Latent Tuberculosis in Pati

Diagnosis of Latent Tuberculosis in Patients With Inflammatory Bowel Disease: Prospective Comparison Between Tuberculin Skin Test and Interferon Gamma Release Assay (IGRA) Test

✍ Ministro, Paula ;Machado, Joana ;Araújo, Ricardo ;Castanheira, António ;Cancela, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 52 KB

501 Discrepant Results Between Routine S

501 Discrepant Results Between Routine Screening for Latent Tuberculosis (Tb) and Quantiferon® in Patients with Inflammatory Bowel Diseases (IBD)

✍ Pavol Papay; Alexander Eser; Petra Paulinska; Cornelia Lichtenberger; Andrea Mik 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 72 KB

P031 DISCREPANT RESULTS BETWEEN ROUTINE

P031 DISCREPANT RESULTS BETWEEN ROUTINE SCREENING FOR LATENT TUBERCULOSIS (TB) AND QUANTIFERON® IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES (IBD)

✍ P. Papay; A. Eser; P. Paulinska; C. Lichtenberger; A. Mikulits; W. Miehsler; C. 📂 Article 📅 2008 🏛 Oxford University Press ⚖ 69 KB

S1126 Immunosuppressive (IS) Therapy Imp

S1126 Immunosuppressive (IS) Therapy Impacts the Results of QuantiFERON® and Tuberculin Skin Test in Routine Screening for Latent Tuberculosis (LTB) in Patients with Inflammatory Bowel Diseases (IBD)

✍ Pavol Papay; Alexander Eser; Wolfgang Miehsler; Cornelia Lichtenberger; Andrea M 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 112 KB

12 - Immunosuppressive (IS) therapy impa

12 - Immunosuppressive (IS) therapy impacts the results of Quantiferon® and tuberculin skin test in routine screening for latent tuberculosis (LTB) in patients with inflammatory bowel diseases (IBD)

✍ P. Papay; A. Eser; W. Miehsler; C. Lichtenberger; A. Mikulits; C. Dejaco; G. Nov 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 54 KB